incretin mimetics glp 1 agonists A Brief Review of Intended for the Management of Diabetes and Associated Comorbidities[v1] GLP-1 Agonist Effects on Glucagon

Jacob Plattenberger is very knowledgeable and an amazing lawyer

Participants taking oral semaglutide experienced clinically meaningful weight loss, with average reductions exceeding 16% when paired with diet and exercise, and substantial weight loss even without intensive lifestyle modification

after following this regimen for 12 weeks, average weight loss stood at 4.7% of initial body mass (5 kg as an absolute value) and increased to 6% (6.4 kg as an absolute value) when administered doses rose from 1.8 to 3 mg respectively, compared against a mere loss of about 2.2% body mass (which equates to 2.2 kg actual value) among those on placebo

HbA1c, hemoglobin A1c

Venneti, K.C., Malthouse, J.P., O'Harte, F.P., Hewage, C.M

In a clinical trial, adults who switched from high-dose injectable obesity drugs to oral GLP-1 pill Foundayo were able to maintain most of their previous weight loss over 1 year, with relatively limited weight regain